In-silico Drug Design and in-silico screening

In-silico drug design can take part much in all stages of drug development from the preclinical discovery stage to late stage clinical development.

During the process of selection of novel drug candidates, many essential steps are taken to eliminate such compounds that have side effects and also show interaction with other drugs. In-silico drug designing softwares show an important role to design progressive proteins or drugs in biotechnology or the pharmaceutical field. 

  • Structural Biology
  • Molecular Docking
  • Virtual Screening Methods
  • Computation approaches for fragment based Drug Discovery
  • Intellectual property issues arising from in silico Discovery
  • Enzyme Inhibitors

Related Conference of In-silico Drug Design and in-silico screening

February 28-March 01, 2019 ANA Crowne Plaza |

Global Pharmaceutical and Pharma Industry Conference

Osaka, Japan
March 18-19, 2019

13th International Conference on Biosimilars and Biologics

Amsterdam | Netherlands
July 26-27, 2019

13th Asian Biologics and Biosimilars Congress

Mercure Albert Park | Melbourne, Australia

In-silico Drug Design and in-silico screening Conference Speakers

Recommended Sessions

Related Journals

Are you interested in